 | Up a level |
Béné, M C; Nebe, T; Bettelheim, P; Buldini, B; Bumbea, H; Kern, W; Lacombe, F; Lemez, P; Marinov, I; Matutes, E; Maynadié, M; Oelschlagel, U; Orfao, A; Schabath, R; Solenthaler, M; Tschurtschenthaler, G; Vladareanu, A M; Zini, G; Faure, G C and Porwit, A (2011). Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia, 25(4), pp. 567-74. Basingstoke: Nature Publishing Group 10.1038/leu.2010.312
Zenhäusern, R; Schmitz, S-F Hsu; Solenthaler, M; Heim, D; Meyer-Monard, S; Hess, U; Leoncini, L; Bargetzi, M; Rufener, B; Tobler, A (2009). Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98). Leukemia & lymphoma, 50(9), pp. 1501-11. London: Informa Healthcare 10.1080/10428190903131755
Meier, N; Lipp, E; Solenthaler, M (2007). [Pancytopenia and hemolysis--diagnosis, differential diagnosis and therapy of pernicious anemia]. Deutsche medizinische Wochenschrift, 132(27), pp. 1469-74. Stuttgart: Thieme 10.1055/s-2007-982055
Schmidt, A; Solenthaler, M (2007). Chronische lymphatische Leukämie: Einteilung, Verlauf, Therapie und Prognose der CLL. Onkologie(1), pp. 20-9. Basel: Karger
Mueller, B U; Buerger, A U; Solenthaler, M; Garamvoelgyi, E M; Oppliger-Leibundgut, E; Fey, M F; Pabst, T (2006). Pleural tumors as sole primary manifestation of acute promyelocytic leukemia. Annals of oncology, 17(4), pp. 722-3. Oxford: Oxford University Press 10.1093/annonc/mdj062
